PMID- 22905392
OWN - NLM
STAT- MEDLINE
DCOM- 20120918
LR  - 20120821
IS  - 0301-1208 (Print)
IS  - 0301-1208 (Linking)
VI  - 39
IP  - 6
DP  - 2002 Dec
TI  - Dendritic cells as natural adjuvants and modulators of immune response in cancer 
      immunotherapy.
PG  - 363-7
AB  - Dendritic cells (DCs) are potent antigen presenting cells. Mature DCs activate 
      antigen specific naive T cells, B cells and NK cells. Under certain conditions, 
      DCs even silence T cell immune responses in vivo, thus, modulating the immune 
      response. This special function of DCs could be exploited in the treatment of 
      cancer, autoimmune disorder and chronic viral infections.
FAU - Alli, Rajshekhar S
AU  - Alli RS
AD  - Centre for Cellular & Molecular Biology, Uppal Road, Hyderabad 500 007, India.
FAU - Khar, Ashok
AU  - Khar A
LA  - eng
PT  - Journal Article
PT  - Review
PL  - India
TA  - Indian J Biochem Biophys
JT  - Indian journal of biochemistry & biophysics
JID - 0310774
RN  - 0 (Adjuvants, Immunologic)
RN  - 0 (Cancer Vaccines)
SB  - IM
MH  - Adjuvants, Immunologic/therapeutic use
MH  - Antigen-Presenting Cells/cytology
MH  - B-Lymphocytes/immunology
MH  - Cancer Vaccines
MH  - Cell Lineage
MH  - Dendritic Cells/*cytology/immunology
MH  - Gene Silencing
MH  - Humans
MH  - Immune System/*physiology
MH  - Immunotherapy/*methods
MH  - Killer Cells, Natural/cytology
MH  - Lymphocyte Subsets/cytology
MH  - Models, Biological
MH  - Neoplasms/*immunology
MH  - T-Lymphocytes/immunology
EDAT- 2002/12/01 00:00
MHDA- 2012/09/19 06:00
CRDT- 2012/08/22 06:00
PHST- 2012/08/22 06:00 [entrez]
PHST- 2002/12/01 00:00 [pubmed]
PHST- 2012/09/19 06:00 [medline]
PST - ppublish
SO  - Indian J Biochem Biophys. 2002 Dec;39(6):363-7.